Nasdaq:MIST

Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

July 02, 2026 21:30 ET  | Source: Milestone Pharmaceuticals Inc. MONTREAL and CHARLOTTE, N.C., July 02, 2026 (GLOBE NEWSWIRE) --…

6 days ago

Milestone Receives FDA Approval of CARDAMYST (etripamil) as First and Only Self-Administered Nasal Spray for Adults with Paroxysmal Supraventricular Tachycardia (PSVT)

First FDA approved treatment in 30+ years for more than 2 million Americans with PSVT Novel nasal spray designed to rapidly…

7 months ago